Global Semiconductor Foundry Market 2014-2018

About Semiconductor Foundries

Semiconductor foundries manufacture integrated chips based on the designs provided by certain companies. The majority of these companies are semiconductor fabless companies, which design and sell hardware devices and semiconductor chipsets while outsourcing the fabrication process of the devices to semiconductor foundries. Semiconductor foundries are also known as semiconductor fabrication plants (usually referred to as fabs).

TechNavio's analysts forecast the Global Semiconductor Foundry market will grow at a CAGR of 12.1 percent over the period 2013-2018.


Covered in this Report

This report covers the present scenario and the growth prospects of the Global Semiconductor Foundry market for the period 2014-2018. To calculate the market size, the report considers revenue generated by semiconductor foundries worldwide.

TechNavio's report, the Global Semiconductor Foundry Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Semiconductor Foundry market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Regions

Americas
EMEA
APAC
Key Vendors
GlobalFoundries Inc.
Samsung Semiconductor Inc.
Semiconductor Manufacturing International Corp.
Taiwan Semiconductor Manufacturing Co. Ltd.
Other Prominent Vendors
Dongbu HiTek
Huahong Grace
IBM Microelectronics
Magnachip Semiconductor Corp.
Powerchip Technology Corp.
TowerJazz
Vanguard International Semiconductor Corp.
WIN Semiconductors Corp.


Market Driver

Rising Demand for Smartphones and Tablets.
For a full, detailed list, view our report.


Market Challenge

Cyclical Nature of the Semiconductor Industry.
For a full, detailed list, view our report.


Market Trend

Short Replacement Cycle of Portable Electronic Devices.
For a full, detailed list, view our report.


Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Global Semiconductor Foundry Market 2014-2018


RELATED VIDEO:

Global Ice Cream Market: Merger and Acquisitions March 2014

Synopsis

The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global ice cream market during March 2014.


Summary

Using this report, dealmakers will effectively gain an insight into deal activity of the global ice cream market throughout the month. Additionally, the report provides an overview of all the partnering, alliances, and M&A deals announced worldwide.

The monthly report provides the reader with the top-line data necessary to quickly keep abreast of deal activity in the global ice cream market on a monthly basis.


Reasons to Buy

The report provides a snapshot of the deal activity trends in the global ice cream market in March 2014. The report is a mixture of graphs, charts, tables and text in an effort to give the reader the maximum possible information in the most efficient and visually appealing manner.

The report provides an overview of the deal activity across various deal types in the month of March 2014 in terms of deal status and deal type.


Table of Contents

1 Introduction
1.1 What is this Report About?
1.2 Definitions
1.3 Summary Methodology
2 Deal Analysis
2.1 Analysis by Deal Status - Global Ice Cream Market
2.2 Analysis by Deal Type - Global Ice Cream Market
3 China Huiyuan Juice Group to issue shares in private placement to Suntory Holdings
3.1 Deal Facts
3.2 Deal in Brief
3.3 Target Company Information
3.4 Acquirer Company Information
3.5 Company Financial Information
3.6 Deal Financials
3.7 Company Financials
3.8 Financial Information
3.9 Financial Ratios
4 IRPLAST and P.E. LABELLERS partner with Koninklijke FrieslandCampina for heat-shrinkable labels
4.1 Deal Facts
4.2 Deal in Brief
4.3 Target Company Information
5 Unilever raises US$415.26 million by issuing fixed rate notes due 2018
5.1 Deal Facts
5.2 Deal in Brief
5.3 Deal Rationale
5.4 Company Financial Information
5.5 Company Financials
5.6 Financial Advisors
6 Genmont Biotech to fully acquire White-Wood-House Foods
6.1 Deal Facts
6.2 Deal in Brief
6.3 Companies Involved
6.4 Vendor Company Information
6.5 Target Company Information
6.6 Company Financial Information
6.7 Deal Financials
7 Agrokor to acquire 8.43% stake in Mercator from Pivovarna Lasko
7.1 Deal Facts
7.2 Deal in Brief
7.3 Acquirer Company Information
7.4 Vendor Company Information
7.5 Target Company Information
8 Unilever acquires Qinyuan Group
8.1 Deal Facts
8.2 Deal in Brief
8.3 Deal Rationale
8.4 Acquirer Company Information
8.5 Target Company Information
8.6 Company Financial Information
8.7 Deal Financials
9 Appendix
9.1 About Canadean
9.2 Disclaimer

To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Global Ice Cream Market: Merger and Acquisitions March 2014


RELATED VIDEO:

OTT Video Market Attractiveness Index - Worldwide Country Rankings, Market Drivers and Positioning Strategies

A new report by Pyramid Research, 'OTT Video Market Attractiveness Index: Worldwide Country Rankings, Market Drivers and Positioning Strategies,' examines the growth potential of OTT video services worldwide, providing insight into the opportunity to derive value from them. In order to assess the strength of the OTT video opportunity in different countries, Pyramid Research has especially for this study developed the proprietary 'OTT Video Market Attractiveness Index.' The 50 main markets of the world are ranked across a number of quantitative and qualitative indicators, providing an effective framework for an assessment of which ones offer the best opportunity for OTT video service providers and a methodical identification of growth markets.


Key Findings

* The largest markets - primarily China, Russia, Mexico and Brazil among emerging markets, and the US and Japan among developed markets - will provide the most attractive opportunities for OTTs.
* The ability to derive value from premium content and the rich HD and 4K formats will be critical to the success of OTTs: Given the low margins in the OTT video business, effective monetization of premium content and formats is critical to boosting revenue.
* Country-level content and regulatory frameworks will also be critical to the success of OTT: Digital content release windows, regulatory frameworks - including neutrality regulations and market-specific rules for the provision of video services - the extent of piracy, OTT taxation and other local factors all go into assessing the OTT opportunity in a given market.
* The revenue opportunity will be greater in the markets where 4G services are better established: These are the markets where mobile operators are able to more effectively target online video services to their customers.
* We expect favorable infrastructural conditions to make CEE a hotspot for OTT video: Russia and the other major CEE markets have benefited and will continue to benefit from state-of-the-art broadband infrastructure and high-speed connections.


Synopsis

The OTT Video Market Attractiveness Index research report assesses the strength of the OTT video opportunity across the 50 countries covered by Pyramid Research's Media Forecasts. The report and the index show an overall level of market attractiveness that can be easily used to pinpoint how any of these markets across the world fares on a variety of issues, from broadband infrastructure to pay-TV market dynamics, content licensing and regulatory frameworks.

The report is based on Pyramid Research's OTT Video Market Attractiveness Index, a country-level quantitative index constructed specifically for this report. The Index is a composite rating of countries based on their scores in three subindexes - OTT Readiness, OTT Intensity and Local Factors. Each subindex further consists of 3-4 quantitative and qualitative indicators, comprising country-level broadband and pay-TV markets as well as socioeconomic indicators.

The resulting Index shows an overall level of attractiveness that can easily be used to pinpoint how markets across the world fare on a variety of key factors, from pay-TV demand and growth trajectories to the status of their broadband infrastructure, regulations and content licensing frameworks.

The index results are grouped around a number of key themes, which are discussed and analyzed in order to explain how the OTT video opportunity is taking shape across different global markets. These key themes include: The importance of addressing large broadband markets to build scalable businesses. The factors guiding the formation of online video audiences; The drivers behind the revenue opportunity in different markets; The role of content licensing and regulatory frameworks in the viability and success of OTT initiatives.

Section 1 of the report explains the methodology used in the Index. Section 2 is a strategic analysis of the results of the OTT Video Market Attractiveness Index. Section 3 is a strategic analysis of the emerging-markets results of the OTT Video Market Attractiveness Index. Section 4 provides key takeaways of the Index rankings.


Reasons to Buy

* The global OTT attractiveness rankings resulting from the Index shows an overall level of market attractiveness, which can be easily used to pinpoint how any market across the world fares on a variety of issues, from broadband infrastructure to pay-TV market dynamics, content licensing and regulatory frameworks.
* The diversity of data used to construct the Index makes it possible to identify which markets globally can be most appealing to OTT providers, and to understand the socioeconomic strengths and weaknesses that boost or burden the OTT opportunity in each.
* The report provides a deep dive into the key drivers behind the uptake of OTT video services in emerging markets, including Latin America (focusing on Brazil and Mexico), Central and Eastern Europe, (focusing on Russia), Asia-Pacific (China) and the Middle East region.
* The broad but detailed perspective will help pay-TV operators, telcos, pure-play OTTs and investors in different regions identify and assess opportunities to deploy OTT video services.


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

OTT Video Market Attractiveness Index - Worldwide Country Rankings, Market Drivers and Positioning Strategies


RELATED VIDEO:

Global Confectionery Market: Merger and Acquisitions March 2014

Synopsis

The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global confectionery market during March 2014.


Summary

Using this report, dealmakers will effectively gain an insight into deal activity of the global confectionery market throughout the month. Additionally, the report provides an overview of all the partnering, alliances, and M&A deals announced worldwide.

The monthly report provides the reader with the top-line data necessary to quickly keep abreast of deal activity in the global confectionery market on a monthly basis.


Reasons to Buy

The report provides a snapshot of the deal activity trends in the global confectionery market in March 2014. The report is a mixture of graphs, charts, tables and text in an effort to give the reader the maximum possible information in the most efficient and visually appealing manner.

The report provides an overview of the deal activity across various deal types in the month of March 2014 in terms of deal status and deal type.

Table of Contents

1 Introduction
1.1 What is this Report About?
1.2 Definitions
1.3 Summary Methodology
2 Deal Analysis
2.1 Analysis by Deal Status - Global Confectionery Market
2.2 Analysis by Deal Type - Global Confectionery Market
3 Unilever raises US$415.26 million by issuing fixed rate notes due 2018
3.1 Deal Facts
3.2 Deal in Brief
3.3 Deal Rationale
3.4 Company Financial Information
3.5 Company Financials
3.6 Financial Advisors:
4 Natra sells 8% stake in Natraceutical
4.1 Deal Facts
4.2 Deal in Brief
4.3 Vendor Company Information
4.4 Target Company Information
4.5 Company Financial Information
5 Prada to acquire 80% stake in Marchesi Angelo
5.1 Deal Facts
5.2 Deal in Brief
5.3 Deal Rationale
5.4 Acquirer Company Information
5.5 Vendor Company Information
5.6 Target Company Information
5.7 Company Financial Information
6 Davide Campari to acquire 100% stake in Forty Creek Distillery
6.1 Deal Facts
6.2 Deal in Brief
6.3 Deal Rationale
6.4 Acquirer Company Information
6.5 Target Company Information
6.6 Company Financial Information
6.7 Deal Financials
6.8 Payment Information
7 Lindt and Sprungli to form joint venture with CRM Group
7.1 Deal Facts
7.2 Deal in Brief
7.3 Deal Rationale
7.4 Target Company Information
8 Mentor Capital acquires 60% stake in Bhang Chocolate
8.1 Deal Facts
8.2 Deal in Brief
8.3 Companies Involved
8.4 Acquirer Company Information
8.5 Target Company Information
8.6 Company Financial Information
8.7 Deal Financials
9 Nestle Holdings prices medium term notes offering for US$225.85 million
9.1 Deal Facts
9.2 Deal in Brief
9.3 Company Financial Information
9.4 Company Financials
9.5 Financial Advisors:
10 Hero Group to acquire 50% stake in Hero Gida Sanayi Ve Ticaret
10.1 Deal Facts
10.2 Deal in Brief
10.3 Deal Rationale
10.4 Acquirer Company Information
10.5 Vendor Company Information
10.6 Target Company Information
10.7 Company Financial Information
11 Fondo Strategico Italiano to acquire 30% stake in Deoleo
11.1 Deal Facts
11.2 Deal in Brief
11.3 Acquirer Company Information
11.4 Target Company Information
11.5 Company Financial Information
12 Alliance Consumer Growth invests in Ripple Brand Collective
12.1 Deal Facts
12.2 Deal in Brief
12.3 Deal Rationale
12.4 Acquirer Company Information
12.5 Target Company Information
12.6 Company Financial Information
13 Flowers Foods partners with Hershey Company
13.1 Deal Facts
13.2 Deal in Brief
13.3 Deal Rationale
13.4 Target Company Information
14 Unilever acquires Qinyuan Group
14.1 Deal Facts
14.2 Deal in Brief
14.3 Deal Rationale
14.4 Acquirer Company Information
14.5 Target Company Information
14.6 Company Financial Information
14.7 Deal Financials
15 Appendix
15.1 About Canadean
15.2 Disclaimer


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Global Confectionery Market: Merger and Acquisitions March 2014


RELATED VIDEO:

Dengue Market Research Reports and Pipeline Review

Global Markets Directs, Dengue - Pipeline Review, H1 2014, provides an overview of the Dengue therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by medicine target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dengue and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational medicines from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Medicine profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

* The report provides a snapshot of the global therapeutic landscape of Dengue
* The report reviews key pipeline products under medicine profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
* The report reviews key players involved in the therapeutics development for Dengue and enlists all their major and minor projects
* The report summarizes all the dormant and discontinued pipeline projects
* A review of the Dengue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
* A detailed assessment of monotherapy and combination therapy pipeline projects
* Coverage of the Dengue pipeline on the basis of target, MoA, route of administration and molecule type
* Latest news and deals relating related to pipeline products


Reasons to buy

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Develop strategic initiatives by understanding the focus areas of leading companies
* Identify and understand important and diverse types of therapeutics under development for Dengue
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Devise corrective measures for pipeline projects by understanding Dengue pipeline depth and focus of Indication therapeutics
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Dengue Market Research Reports and Pipeline Review


RELATED VIDEO:

Kidney Disease Market Research Reports and Pipeline Review

Global Markets Directs, Kidney Disease - Pipeline Review, H1 2014, provides an overview of the Kidney Diseases therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Kidney Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Disease and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

* The report provides a snapshot of the global therapeutic landscape of Kidney Disease
* The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
* The report reviews key players involved in the therapeutics development for Kidney Disease and enlists all their major and minor projects
* The report summarizes all the dormant and discontinued pipeline projects
* A review of the Kidney Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
* A detailed assessment of monotherapy and combination therapy pipeline projects
* Coverage of the Kidney Disease pipeline on the basis of target, MoA, route of administration and molecule type
* Latest news and deals relating related to pipeline products


Reasons to buy

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Develop strategic initiatives by understanding the focus areas of leading companies
* Identify and understand important and diverse types of therapeutics under development for Kidney Disease
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Devise corrective measures for pipeline projects by understanding Kidney Disease pipeline depth and focus of Indication therapeutics
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Kidney Disease Market Research Reports and Pipeline Review


RELATED VIDEO:

Fatigue Market Research Reports and Pipeline Review

Global Markets Directs, Fatigue - Pipeline Review, H1 2014, provides an overview of the Fatigues therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Fatigue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fatigue and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

* The report provides a snapshot of the global therapeutic landscape of Fatigue
* The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
* The report reviews key players involved in the therapeutics development for Fatigue and enlists all their major and minor projects
* The report summarizes all the dormant and discontinued pipeline projects
* A review of the Fatigue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
* A detailed assessment of monotherapy and combination therapy pipeline projects
* Coverage of the Fatigue pipeline on the basis of target, MoA, route of administration and molecule type
* Latest news and deals relating related to pipeline products


Reasons to buy

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Develop strategic initiatives by understanding the focus areas of leading companies
* Identify and understand important and diverse types of therapeutics under development for Fatigue
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Devise corrective measures for pipeline projects by understanding Fatigue pipeline depth and focus of Indication therapeutics
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Fatigue Market Research Reports and Pipeline Review


RELATED VIDEO: